Gene · 53637
Papers1,387
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,387
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Therapeutic Potential of Fingolimod and Dimethyl Fumarate in Preclinical Pancreatic Cancer Models. | Oncol Res | 2026 | 41799523 | PubTator, text mining | PubMed |
| Natural killer cells, macrophages and dendritic cells as innate immune therapies for blood cancers. | Ann Hematol | 2026 | 41770372 | PubTator, text mining | PubMed |
| Anti-thymocyte globulin-resistant CD4+ memory T cells contribute to haplo-fever after allogeneic hematopoietic stem cell transplantation. | Blood Sci | 2026 | 41768796 | PubTator, text mining | PubMed |
| The Acid sphingomyelinase/ceramide System in Idiopathic Inflammatory Myopathies: a Potential Treatment Target. | Inflammation | 2026 | 41721077 | PubTator, text mining | PubMed |
| Efferocytosis deficiency exacerbates local inflammation and predicts recurrence in chronic rhinosinusitis with nasal polyps. | J Allergy Clin Immunol | 2026 | 41638263 | PubTator, text mining | PubMed |
| Etrasimod: A Next-Generation S1P Receptor Modulator for Ulcerative Colitis - Mechanistic Insights and Clinical Progress. | Zhongguo Ying Yong Sheng Li Xue Za Zhi | 2026 | 41630551 | PubTator, text mining | PubMed |
| Unraveling the Interplay of D-2-HG in Glioblastoma Tumorigenesis via Integrated Machine Learning and Molecular Docking Analysis. | Front Biosci (Landmark Ed) | 2026 | 41609083 | PubTator, text mining | PubMed |
| Type I interferon drives dysfunction of a distinct CD8+ HLA-DRB1+ T cell subset in systemic lupus erythematosus. | medRxiv | 2026 | 41607660 | PubTator, text mining | PubMed |
| Synthetic strategies and therapeutic insights into FDA-approved indole-containing drugs. | J Enzyme Inhib Med Chem | 2026 | 41601150 | PubTator, text mining | PubMed |
| Clonal CD8+ T cells populate the leptomeninges and coordinate with immune cells in human degenerative brain diseases. | Nat Immunol | 2026 | 41593242 | PubTator, text mining | PubMed |
| Sphingosine-1-Phosphate Receptor 5 Signaling Is Redundant in Preclinical Models of Inflammatory Bowel Disease. | Cell Mol Gastroenterol Hepatol | 2026 | 41548659 | PubTator, text mining | PubMed |
| Extracellular vesicle-derived miR-760 as a novel promising candidate biomarker differentiating stable RRMS from SPMS. | Sci Rep | 2026 | 41535347 | PubTator, text mining | PubMed |
| The antitumor mechanisms of Huangqin Houpo decoction and its effect on chemotherapy-induced toxicity in colorectal cancer. | Phytomedicine | 2026 | 41435607 | PubTator, text mining | PubMed |
| Etrasimod: Review of the safety and practical management considerations of a new oral therapy for the treatment of ulcerative colitis. | Gastroenterol Hepatol | 2026 | 41429351 | PubTator, text mining | PubMed |
| Paracrine signaling mediators of vascular endothelial barrier dysfunction in sepsis: implications for therapeutic targeting. | Tissue Barriers | 2026 | 40376886 | PubTator, text mining | PubMed |
| Multi-omics and Mendelian randomization identify S1PR5 as a causal protective gene and NK cell-mediated prognostic biomarker in lung adenocarcinoma. | Transl Lung Cancer Res | 2025 | 41132951 | PubTator, text mining | PubMed |
| mcRigor: a statistical method to enhance the rigor of metacell partitioning in single-cell data analysis. | Nat Commun | 2025 | 41022768 | PubTator, text mining | PubMed |
| S1PR5 as a prognostic biomarker in colon cancer: insights into efferocytosis-related mechanisms and immune modulation. | J Mol Histol | 2025 | 40952538 | PubTator, text mining | PubMed |
| Role of immune cell subsets in liver fibrosis through single-cell RNA sequencing and array. | Cancer Biomark | 2025 | 40938627 | PubTator, text mining | PubMed |
| Discovery and SAR study of highly selective and potent 1,2,4-oxadiazole-based S1PR1 agonists. | Eur J Med Chem | 2025 | 40911968 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53637/papers?page=2